231 related articles for article (PubMed ID: 23307570)
1. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny.
Pfaff N; Lachmann N; Ackermann M; Kohlscheen S; Brendel C; Maetzig T; Niemann H; Antoniou MN; Grez M; Schambach A; Cantz T; Moritz T
Stem Cells; 2013 Mar; 31(3):488-99. PubMed ID: 23307570
[TBL] [Abstract][Full Text] [Related]
2. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy.
Ackermann M; Lachmann N; Hartung S; Eggenschwiler R; Pfaff N; Happle C; Mucci A; Göhring G; Niemann H; Hansen G; Schambach A; Cantz T; Zweigerdt R; Moritz T
Biomaterials; 2014 Feb; 35(5):1531-42. PubMed ID: 24290698
[TBL] [Abstract][Full Text] [Related]
3. Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells.
Hoffmann D; Schott JW; Geis FK; Lange L; Müller FJ; Lenz D; Zychlinski D; Steinemann D; Morgan M; Moritz T; Schambach A
Gene Ther; 2017 May; 24(5):298-307. PubMed ID: 28346436
[TBL] [Abstract][Full Text] [Related]
4. A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells.
Müller-Kuller U; Ackermann M; Kolodziej S; Brendel C; Fritsch J; Lachmann N; Kunkel H; Lausen J; Schambach A; Moritz T; Grez M
Nucleic Acids Res; 2015 Feb; 43(3):1577-92. PubMed ID: 25605798
[TBL] [Abstract][Full Text] [Related]
5. Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter.
Brendel C; Müller-Kuller U; Schultze-Strasser S; Stein S; Chen-Wichmann L; Krattenmacher A; Kunkel H; Dillmann A; Antoniou MN; Grez M
Gene Ther; 2012 Oct; 19(10):1018-29. PubMed ID: 22071971
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.
Zhang F; Thornhill SI; Howe SJ; Ulaganathan M; Schambach A; Sinclair J; Kinnon C; Gaspar HB; Antoniou M; Thrasher AJ
Blood; 2007 Sep; 110(5):1448-57. PubMed ID: 17456723
[TBL] [Abstract][Full Text] [Related]
7. Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression.
Krinner S; Heitzer A; Asbach B; Wagner R
Hum Gene Ther; 2015 Dec; 26(12):826-40. PubMed ID: 26414116
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral MGMT(P140K)-mediated in vivo selection employing a ubiquitous chromatin opening element (A2UCOE) linked to a cellular promoter.
Phaltane R; Lachmann N; Brennig S; Ackermann M; Modlich U; Moritz T
Biomaterials; 2014 Aug; 35(25):7204-13. PubMed ID: 24875758
[TBL] [Abstract][Full Text] [Related]
9. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
10. Sustained and regulated gene expression by Tet-inducible "all-in-one" retroviral vectors containing the HNRPA2B1-CBX3 UCOE
Cullmann K; Blokland KEC; Sebe A; Schenk F; Ivics Z; Heinz N; Modlich U
Biomaterials; 2019 Feb; 192():486-499. PubMed ID: 30508767
[TBL] [Abstract][Full Text] [Related]
11. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.
Zhang F; Frost AR; Blundell MP; Bales O; Antoniou MN; Thrasher AJ
Mol Ther; 2010 Sep; 18(9):1640-9. PubMed ID: 20588258
[TBL] [Abstract][Full Text] [Related]
12. Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector.
Dighe N; Khoury M; Mattar C; Chong M; Choolani M; Chen J; Antoniou MN; Chan JK
PLoS One; 2014; 9(8):e104805. PubMed ID: 25118036
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a core region in the A2UCOE that confers effective anti-silencing activity.
Zhang F; Santilli G; Thrasher AJ
Sci Rep; 2017 Aug; 7(1):10213. PubMed ID: 28860464
[TBL] [Abstract][Full Text] [Related]
14. Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.
Kamata M; Liu S; Liang M; Nagaoka Y; Chen IS
Hum Gene Ther; 2010 Nov; 21(11):1555-67. PubMed ID: 20524893
[TBL] [Abstract][Full Text] [Related]
15. Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure.
Hino S; Fan J; Taguwa S; Akasaka K; Matsuoka M
Gene Ther; 2004 May; 11(10):819-28. PubMed ID: 14985785
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a reporter system to monitor silencing status in induced pluripotent stem cell lines.
Donai K; Kuroda K; Guo Y; So KH; Sone H; Kobayashi M; Nishimori K; Fukuda T
Anal Biochem; 2013 Dec; 443(1):104-12. PubMed ID: 23973628
[TBL] [Abstract][Full Text] [Related]
17. Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing.
Knight S; Zhang F; Mueller-Kuller U; Bokhoven M; Gupta A; Broughton T; Sha S; Antoniou MN; Brendel C; Grez M; Thrasher AJ; Collins M; Takeuchi Y
J Virol; 2012 Sep; 86(17):9088-95. PubMed ID: 22696657
[TBL] [Abstract][Full Text] [Related]
18. The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function.
Kunkiel J; Gödecke N; Ackermann M; Hoffmann D; Schambach A; Lachmann N; Wirth D; Moritz T
Sci Rep; 2017 Aug; 7(1):7919. PubMed ID: 28801671
[TBL] [Abstract][Full Text] [Related]
19. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.
Rivella S; Sadelain M
Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154
[TBL] [Abstract][Full Text] [Related]
20. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
